Alexander V. Chervonsky

Alexander V. Chervonsky

Auto-generated profile, based on publicly available information

Alexander V. Chervonsky

Department of Pathology, The University of Chicago

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2008 in Nature
Verified
Journal Article
Open access
PDF file
LWLi Wen
Li Wen
RLRuth E. Ley
Ruth E. Ley
PVPavel Yu. Volchkov
Pavel Yu. Volchkov
PSPeter B. Stranges
Peter B. Stranges
LALia Avanesyan
Lia Avanesyan
ACAlexander V. Chervonsky
Alexander V. Chervonsky
The incidence of autoimmune diabetes in NOD (non-obese diabetic) mice, a lab model for type 1 diabetes, varies depending on the conditions in which they are kept. In particular, NOD mice exposed to killed mycobacteria and other microbial products are protected against the development of diabetes, suggesting the involvement of the rapid innate immune response. Experiments in NOD mice deficient in innate immunity — through the absence of the Toll-like receptor signal adaptor protein MyD88 — now show that both innate immunity and intestinal microbiota influence predisposition to diabetes. Germ-free MyD88-negative mice developed robust diabetes, yet in mice with a complement of gut microbes similar to the normal human gut, diabetes was reduced. This raises the prospect that live 'friendly' microbes, or microbial products might be therapeutic options for type 1 diabetes. The effect of deficiency of MyD88 on the generation of type 1 diabetes (T1D) has been investigated through the generation of congenic strains in the non-obese diabetic (NOD) mouse model. It is found that in specific pathogen-free conditions, MyD88-deficiency attenuates T1D, indicating that the interaction of intestinal microbes with the innate immune system is a critical factor in modifying susceptibility to type 1 diabetes. Type 1 diabetes (T1D) is a debilitating autoimmune disease that results from T-cell-mediated destruction of insulin-producing β-cells. Its incidence has increased during the past several decades in developed countries1,2, suggesting that changes in the environment (including the human microbial environment) may influence disease pathogenesis. The incidence of spontaneous T1D in non-obese diabetic (NOD) mice can be affected by the microbial environment in the animal housing facility3 or by exposure to microbial stimuli, such as injection with mycobacteria or various microbial products4,5. Here we show that specific pathogen-free NOD mice lacking MyD88 protein (an adaptor for multiple innate immune receptors that recognize microbial stimuli) do not develop T1D. The effect is dependent on commensal microbes because germ-free MyD88-negative NOD mice develop robust diabetes, whereas colonization of these germ-free MyD88-negative NOD mice with a defined microbial consortium (representing bacterial phyla normally present in human gut) attenuates T1D. We also find that MyD88 deficiency changes the composition of the distal gut microbiota, and that exposure to the microbiota of specific pathogen-free MyD88-negative NOD donors attenuates T1D in germ-free NOD recipients. Together, these findings indicate that interaction of the intestinal microbes with the innate immune system is a critical epigenetic factor modifying T1D predisposition.

1 August 2013 in Immunity
Verified
Journal Article
Closed access
LYLeonid Yurkovetskiy
Leonid Yurkovetskiy
MBMichael Burrows
Michael Burrows
AKAly A. Khan
Aly A. Khan
LGLaura Graham
Laura Graham
PVPavel Volchkov
Pavel Volchkov
ACAlexander V. Chervonsky
Alexander V. Chervonsky

1 October 2014 in Nature
Verified
Journal Article
Open access
PDF file
JPJoseph M. Pickard
Joseph M. Pickard
CMCorinne F. Maurice
Corinne F. Maurice
MKMelissa A. Kinnebrew
Melissa A. Kinnebrew
MAMichael C. Abt
Michael C. Abt
DSDominik Schenten
Dominik Schenten
ACAlexander V. Chervonsky
Alexander V. Chervonsky
Systemic exposure to Toll-like receptor (TLR) ligands during sickness is shown to induce fucosylation of the small intestine in mice; some of the fucose is shed into the intestinal lumen, where it provides nourishment for the microbiota. A healthy gut microbiota is important for the host's well being, so it would make sense for host resources to be expended to protect 'good' microbes during a systemic response to infection. L-fucosylation could be such a resource: L-fucose attached to glycoproteins and glycolipids is accessible for microbial, but not for host energy harvest. Joseph Pickard et al. show that systemic exposure to Toll-like receptor (TLR) ligands induces fucosylation of the small intestine epithelium via a dendritic cell and interleukin-22 (IL-22) dependent mechanism. Some of the fucose is shed into the intestinal lumen where it provides nourishment for the microbiota, and contributes to the production of short-chain fatty acids, which are beneficial for the host. Systemic infection induces conserved physiological responses that include both resistance and ‘tolerance of infection’ mechanisms1. Temporary anorexia associated with an infection is often beneficial2,3, reallocating energy from food foraging towards resistance to infection4 or depriving pathogens of nutrients5. However, it imposes a stress on intestinal commensals, as they also experience reduced substrate availability; this affects host fitness owing to the loss of caloric intake and colonization resistance (protection from additional infections)6. We hypothesized that the host might utilize internal resources to support the gut microbiota during the acute phase of the disease. Here we show that systemic exposure to Toll-like receptor (TLR) ligands causes rapid α(1,2)-fucosylation of small intestine epithelial cells (IECs) in mice, which requires the sensing of TLR agonists, as well as the production of interleukin (IL)-23 by dendritic cells, activation of innate lymphoid cells and expression of fucosyltransferase 2 (Fut2) by IL-22-stimulated IECs. Fucosylated proteins are shed into the lumen and fucose is liberated and metabolized by the gut microbiota, as shown by reporter bacteria and community-wide analysis of microbial gene expression. Fucose affects the expression of microbial metabolic pathways and reduces the expression of bacterial virulence genes. It also improves host tolerance of the mild pathogen Citrobacter rodentium. Thus, rapid IEC fucosylation appears to be a protective mechanism that utilizes the host’s resources to maintain host–microbial interactions during pathogen-induced stress.

1 February 2010 in Immunity
Verified
Journal Article
Closed access
HLHeung Kyu Lee
Heung Kyu Lee
LMLisa Mattei
Lisa Mattei
BSBenjamin E. Steinberg
Benjamin E. Steinberg
PAPhilipp Alberts
Philipp Alberts
YLYun Hee Lee
Yun Hee Lee
AIAkiko Iwasaki
Akiko Iwasaki

1 April 1997 in Cell
Verified
Journal Article
Open access
ACAlexander V Chervonsky
Alexander V Chervonsky
YWYi Wang
Yi Wang
FWF.Susan Wong
F.Susan Wong
IVIrene Visintin
Irene Visintin
RFRichard A Flavell
Richard A Flavell
LMLouis A Matis
Louis A Matis
Immunologically privileged sites express Fas ligand (FasL), which protects them from attack by activated T cells that express Fas and die upon contact with FasL. In an attempt to protect nonobese diabetic mice (NOD) from autoimmune diabetes, we made FasL transgenic NOD mice using the beta cell-specific rat insulin-1 promoter. Surprisingly, these transgenic mice showed heightened sensitivity to diabetogenic T cells, which was due to self-destruction of beta cells upon T cell-mediated induction of Fas. Fas-negative NOD(lpr/lpr) animals were resistant to diabetogenic T cells and to spontaneous diabetes. Thus, induction of Fas expression on beta cells and their subsequent destruction constitutes the main pathogenic mechanism in autoimmune diabetes.

14 October 2011 in Science
Verified
Journal Article
Closed access
PDF file
MKMelissa Kane
Melissa Kane
LCLaure K. Case
Laure K. Case
KKKaryl Kopaskie
Karyl Kopaskie
AKAlena Kozlova
Alena Kozlova
CMCameron MacDearmid
Cameron MacDearmid
TGTatyana Golovkina
Tatyana Golovkina
Commensal microflora promote the pathogenesis of mucosally acquired viruses.